Can ELISPOT Be Applied to A Clinical Setting as A Diagnostic Utility for Neuroborreliosis?

The aim of this prospective study was to investigate the diagnostic performance of Borrelia (Bb)-induced interferon (IFN)-γ secretion detected by ELISPOT modified to be feasible for clinical laboratories as a supplementary test to the laboratory diagnosis of Lyme neuroborreliosis (LNB) in an endemic...

Full description

Bibliographic Details
Main Authors: Ingvar Eliasson, Christina Ekerfelt, Jan Ernerudh, Clara Nyberg, Barbro H. Skogman, Dag Nyman, Pia Forsberg, Marika Nordberg
Format: Article
Language:English
Published: MDPI AG 2012-06-01
Series:Cells
Subjects:
Online Access:http://www.mdpi.com/2073-4409/1/2/153